Orange Book product · Generic (ANDA)
OXAPROZIN
OXAPROZIN
At a glance
Sep 02, 2004
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 02, 2004
22 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
OXAPROZIN
Strength
600MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 075987
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of OXAPROZIN
- 2023COXANTOBrand (NDA)
NDA 217927 · SOLUBIOMIX
- 1992DAYPROBrand (NDA)
NDA 018841 · PFIZER
- 2017OXAPROZINGeneric (ANDA)
ANDA 208633 · AMNEAL PHARMS CO
- 2002OXAPROZINGeneric (ANDA)
ANDA 075849 · TEVA
- 2002OXAPROZINGeneric (ANDA)
ANDA 075846 · IVAX SUB TEVA PHARMS
- 2002OXAPROZINGeneric (ANDA)
ANDA 075844 · SUN PHARM INDS INC
- 2001OXAPROZINGeneric (ANDA)
ANDA 075843 · ACTAVIS ELIZABETH
- 2001OXAPROZINGeneric (ANDA)
ANDA 075851 · PHARMOBEDIENT
- 2001OXAPROZINGeneric (ANDA)
ANDA 075850 · SANDOZ
- 2001OXAPROZINGeneric (ANDA)
ANDA 075842 · AARXION ANDA HLDING
- 2001OXAPROZINGeneric (ANDA)
ANDA 075847 · MYLAN PHARMS INC
- 2001OXAPROZINGeneric (ANDA)
ANDA 075848 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

